Holly A. Johnson

1.8k total citations
36 papers, 1.4k citations indexed

About

Holly A. Johnson is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Holly A. Johnson has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Holly A. Johnson's work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (6 papers) and Soil Carbon and Nitrogen Dynamics (6 papers). Holly A. Johnson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (6 papers) and Soil Carbon and Nitrogen Dynamics (6 papers). Holly A. Johnson collaborates with scholars based in United States, Venezuela and United Kingdom. Holly A. Johnson's co-authors include Jon D. Hanson, Mark A. Liebig, A. B. Frank, J. D. Berdahl, Mario E. Biondini, Charlene A. Audette, Hans K. Erickson, Jan Pinkas, J. M. Krupinsky and Doris Wagner and has published in prestigious journals such as Blood, Cancer Research and Phytochemistry.

In The Last Decade

Holly A. Johnson

33 papers receiving 1.3k citations

Peers

Holly A. Johnson
Hai Long China
A.K. Kashyap India
Xuemei Ji China
Michal Martinka Slovakia
Andrew McEwan United Kingdom
Xianguo Wang China
Gláucia Mendes Souza Brazil
Bingrui Wang China
Sergey E. Sedykh Russia
Shuyong Zhang China
Hai Long China
Holly A. Johnson
Citations per year, relative to Holly A. Johnson Holly A. Johnson (= 1×) peers Hai Long

Countries citing papers authored by Holly A. Johnson

Since Specialization
Citations

This map shows the geographic impact of Holly A. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly A. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly A. Johnson more than expected).

Fields of papers citing papers by Holly A. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly A. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly A. Johnson. The network helps show where Holly A. Johnson may publish in the future.

Co-authorship network of co-authors of Holly A. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Holly A. Johnson. A scholar is included among the top collaborators of Holly A. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly A. Johnson. Holly A. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Holly A., et al.. (2024). Percutaneous distal bicortical proximal phalanx osteotomy for second toe deformities – A two-year prospective cohort study. Foot and Ankle Surgery. 30(8). 706–712. 1 indexed citations
2.
Johnson, Holly A., et al.. (2022). A 10-Year Review of Designated Leadership Positions of the American Orthopaedic Foot & Ankle Society (AOFAS). Foot & Ankle Orthopaedics. 7(4). 1768410704–1768410704. 2 indexed citations
3.
Karacosta, Loukia Georgiou, John C. Fisk, Swetha Tati, et al.. (2018). Preclinical Analysis of JAA-F11, a Specific Anti–Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging. Translational Oncology. 11(2). 450–466. 13 indexed citations
4.
Sanderson, Matt A., Holly A. Johnson, & John Hendrickson. (2018). Cover Crop Mixtures Grown for Annual Forage in a Semi‐Arid Environment. Agronomy Journal. 110(2). 525–534. 25 indexed citations
5.
Erickson, Hans K., Gail D. Lewis Phillips, Douglas D. Leipold, et al.. (2014). Mechanistic pharmacokinetic/pharmacodynamic modeling of in vivo tumor uptake, catabolism, and tumor response of trastuzumab maytansinoid conjugates. Cancer Chemotherapy and Pharmacology. 74(5). 969–980. 22 indexed citations
6.
Whiteman, Kathleen R., Holly A. Johnson, Michele Mayo, et al.. (2014). Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models. mAbs. 6(2). 556–566. 50 indexed citations
7.
Erickson, Hans K., Gail D. Lewis Phillips, Douglas D. Leipold, et al.. (2012). The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates. Molecular Cancer Therapeutics. 11(5). 1133–1142. 141 indexed citations
8.
Whiteman, Kathleen R., Holly A. Johnson, Xiuxia Sun, et al.. (2012). Abstract 4628: Anti-tumor activity and pharmacokinetics of the anti-FOLR1-maytansinoid conjugate IMGN853 is maintained over a wide range of maytansinoid-to-antibody ratios. Cancer Research. 72(8_Supplement). 4628–4628. 1 indexed citations
9.
Whiteman, Kathleen R., Holly A. Johnson, Shanqin Xu, Jan Pinkas, & Robert J. Lutz. (2011). Abstract 1781: Lorvotuzumab mertansine (IMGN901) in combination with standard-of-care paclitaxel/carboplatin therapy is highly active in a preclinical xenograft model of ovarian cancer. Cancer Research. 71(8_Supplement). 1781–1781. 3 indexed citations
10.
Kovtun, Yelena, Charlene A. Audette, Michele Mayo, et al.. (2010). Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance. Cancer Research. 70(6). 2528–2537. 194 indexed citations
11.
Whiteman, Kathleen R., Holly A. Johnson, Shanqin Xu, et al.. (2009). Abstract #2799: Combination therapy with IMGN901 and lenalidomide plus low-dose dexamethasone is highly effective in multiple myeloma xenograft models. Cancer Research. 69. 2799–2799. 6 indexed citations
12.
Liebig, Mark A., Holly A. Johnson, Jon D. Hanson, & A. B. Frank. (2005). Soil carbon under switchgrass stands and cultivated cropland. Biomass and Bioenergy. 28(4). 347–354. 176 indexed citations
13.
Frank, A. B., J. D. Berdahl, Jon D. Hanson, Mark A. Liebig, & Holly A. Johnson. (2004). Biomass and Carbon Partitioning in Switchgrass. Crop Science. 44(4). 1391–1396. 180 indexed citations
14.
Hosny, Mohammed, et al.. (2002). Oxidation, Reduction, and Methylation of Carnosic Acid by Nocardia. Journal of Natural Products. 65(9). 1266–1269. 19 indexed citations
15.
Johnson, Holly A., et al.. (2001). NFL1, a Nicotiana tabacumLEAFY-Like Gene, Controls Meristem Initiation and Floral Structure. Plant and Cell Physiology. 42(10). 1130–1139. 92 indexed citations
16.
17.
Johnson, Holly A., et al.. (1998). Annojahnin from Annona jahnii: a possible precursor of mono-tetrahydrofuran acetogenins. Phytochemistry. 49(6). 1609–1616. 13 indexed citations
18.
Johnson, Holly A., et al.. (1998). Bioactive Monoterpenes fromMonarda fistulosa(Lamiaceae). Natural product letters. 11(4). 241–250. 24 indexed citations
19.
Rogers, Lingling L., Lu Zeng, John F. Kozlowski, et al.. (1998). New Bioactive Triterpenoids from Melia volkensii. Journal of Natural Products. 61(1). 64–70. 23 indexed citations
20.
Frazier, N. W., et al.. (1962). Necrotic shock-a virus disease of strawberries.. ˜The œPlant disease reporter. 46. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hai Long Breakdown of academic impact, for papers by A.K. Kashyap Breakdown of academic impact, for papers by Xuemei Ji Breakdown of academic impact, for papers by Michal Martinka Breakdown of academic impact, for papers by Andrew McEwan Breakdown of academic impact, for papers by Xianguo Wang Breakdown of academic impact, for papers by Gláucia Mendes Souza Breakdown of academic impact, for papers by Bingrui Wang Breakdown of academic impact, for papers by Sergey E. Sedykh Breakdown of academic impact, for papers by Shuyong Zhang
Rankless by CCL
2026